Cédric Dray Selected Research

Apelin

11/2021	Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall.
1/2019	Apelin affects the mouse aging urinary peptidome with minimal effects on kidney.
1/2018	Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp.
2/2016	Apelin: an antithrombotic factor that inhibits platelet function.
5/2012	Apelin, a promising target for type 2 diabetes treatment?
2/2012	Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice.
8/2011	Apelin, diabetes, and obesity.
6/2010	Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
11/2008	Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.
6/2008	Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cédric Dray Research Topics

Disease

11	Insulin Resistance 01/2021 - 07/2006
10	Obesity 01/2021 - 12/2005
9	Inflammation (Inflammations) 11/2021 - 07/2006
4	Hyperinsulinism (Hyperinsulinemia) 02/2014 - 10/2008
3	Type 2 Diabetes Mellitus (MODY) 05/2012 - 06/2010
2	Weight Loss (Weight Reduction) 01/2021 - 06/2008
2	Body Weight (Weight, Body) 11/2018 - 10/2008
2	Breast Neoplasms (Breast Cancer) 09/2013 - 02/2011
1	Fatty Liver 03/2022
1	Non-alcoholic Fatty Liver Disease 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2021
1	Sarcopenia 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Hypertrophy 01/2019
1	Metabolic Diseases (Metabolic Disease) 11/2018
1	Overweight 01/2018
1	Werner Syndrome (Werner's Syndrome) 01/2017
1	Cognitive Dysfunction 01/2017
1	Hyperglycemia 06/2016
1	Thrombosis (Thrombus) 02/2016
1	Hemorrhage 02/2016
1	Endotoxemia 02/2014
1	Neoplasms (Cancer) 09/2013

Drug/Important Bio-Agent (IBA)

12	ApelinIBA 11/2021 - 12/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2008
5	LipidsIBA 11/2021 - 10/2009
5	AdipokinesIBA 01/2018 - 12/2005
4	Insulin (Novolin)FDA Link 01/2018 - 07/2006
3	CholesterolIBA 11/2021 - 11/2018
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 02/2012
3	Peptides (Polypeptides)IBA 01/2019 - 05/2012
2	CollagenIBA 01/2019 - 11/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2014 - 10/2008
1	HMGB1 Protein (HMG1)IBA 03/2022
1	Liver X ReceptorsIBA 03/2022
1	cathepsin SIBA 11/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	AlarminsIBA 04/2019
1	Hormones (Hormone)IBA 11/2018
1	Glutens (Glutelin)IBA 11/2018
1	Nonesterified Fatty Acids (NEFA)IBA 11/2018
1	CytokinesIBA 11/2018
1	EnzymesIBA 01/2017
1	DNA HelicasesIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	OxylipinsIBA 01/2016
1	LipopolysaccharidesIBA 02/2014
1	CateninsIBA 09/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2012
1	Peptide Hydrolases (Proteases)FDA Link 02/2011
1	Cathepsin DIBA 02/2011
1	Apelin ReceptorsIBA 06/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2006

Therapy/Procedure

1	Endurance Training 01/2021
1	Subcutaneous Injections 06/2016
1	Therapeutics 09/2013